Basal Ganglia Pathophysiology
151 – 160 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Advances in understanding l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
- Contribution to journal › Article
-
Mark
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia.
- Contribution to journal › Article
- 2006
-
Mark
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis
- Contribution to journal › Article
-
Mark
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
- Contribution to journal › Article
-
Mark
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
- Contribution to journal › Scientific review
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
- Contribution to journal › Letter
-
Mark
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
- Contribution to journal › Article
